Sanara MedTech (SMTI) Equity Ratio (2016 - 2025)
Sanara MedTech's Equity Ratio history spans 15 years, with the latest figure at 0.08 for Q4 2025.
- For Q4 2025, Equity Ratio fell 81.6% year-over-year to 0.08; the TTM value through Dec 2025 reached 0.08, down 81.6%, while the annual FY2025 figure was 0.08, 81.6% down from the prior year.
- Equity Ratio reached 0.08 in Q4 2025 per SMTI's latest filing, down from 0.09 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.91 in Q1 2021 to a low of 0.08 in Q4 2025.
- Average Equity Ratio over 5 years is 0.6, with a median of 0.61 recorded in 2023.
- Peak YoY movement for Equity Ratio: soared 60.62% in 2021, then tumbled 81.6% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.83 in 2021, then dropped by 17.49% to 0.68 in 2022, then dropped by 11.7% to 0.6 in 2023, then dropped by 26.82% to 0.44 in 2024, then crashed by 81.6% to 0.08 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Equity Ratio are 0.08 (Q4 2025), 0.09 (Q3 2025), and 0.36 (Q2 2025).